More articles about Gene Silencing/Gene Editing

The statement recommends that germline genome editing in humans not culminate in pregnancy, but supports in vitro research into potential clinical applications.

Researchers have used the gene-editing tool CRISPR/Cas9 to correct a mutation linked to hypertrophic cardiomyopathy in embryos.

The firm has raised a total of $127 million since it launched in 2016, and plans to use the funds to advance its gene editing technology to the clinic.

The Broad's David Scott and Feng Zhang said whole-genome sequencing could be used to guide RNA selection for individuals undergoing genomic editing therapy.

Researchers from the Broad Institute and Novartis used RNA interference to generate catalogs of genes that cancer cells rely on to grow and survive.

The plaintiffs say the USPTO made several errors when it determined the Broad Institute had the right to patent the use of CRISPR/Cas9 in eukaryotes.

Researchers led by Jennifer Doudna found that the architecture of the Cas1-Cas2 integrase contributes to bacterial adaptive immunity.

The team said the resource allows for single-target or combinatorial genetic screens to be carried out at scale in a multiplexed or arrayed format.

The group will study the potential risks and benefits of using CRISPR/Cas9 to develop gene drive systems for control and manipulation of mosquito populations.

The license is part of an ongoing cancer research collaboration between NovellusDx and Christiana Care's Gene Editing Institute.

The firm recently released two droplet digital PCR-based assays that can characterize edits generated by CRISPR-Cas9 or other genome editing tools.

The UK-based company plans to use the funds to develop an automated, benchtop device for the creation of high-value, genome-edited cell lines.

A new study led by UC-Berkeley scientists shows that an inhibitor protein from a Listeria bacteriophage can block Cas9 from interacting with DNA.

The company said it will use the funds to develop antimicrobial therapeutics based on CRISPR-Cas3 technology.

The two companies plan to combine their respective gene editing and neoantigen discover technologies in order to develop new T cell therapies for cancer patients.

The technology is based on helitrons, a type of eukaryotic transposon that can incorporate multiple copies of a DNA sequence into a genome.

DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.

The deal allows St. Louis-based Canopy to access Cosmo's Japanese academic and pharma customers for its gene editing and personalized medicine technologies.

The company said its proxy-CRISPR tool can facilitate precise gene editing and eliminates the need for genetic engineering of naturally occurring CRISPR proteins.

Taconic Biosciences said that it will use ERS Genomics' CRISPR-Cas9 technology to generate unique murine models.

Pages

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.